Biofrontera Inc. Receives Nasdaq Delisting Notice for Sub-$1.00 Bid Price

summarizeSummary

Biofrontera Inc. received a Nasdaq notice for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day compliance period to avoid potential delisting.

check_boxKey Events

• Nasdaq Non-Compliance Notice

  On December 31, 2025, Biofrontera Inc. received a letter from Nasdaq notifying it of non-compliance with Listing Rule 5550(a)(2) due to its common stock closing below $1.00 for 34 consecutive business days.

• 180-Day Compliance Period

  The company has 180 calendar days, until June 30, 2026, to regain compliance by achieving a closing bid price of at least $1.00 for a minimum of 10 consecutive business days.

• Potential Delisting Risk

  Failure to regain compliance could lead to a delisting notice from Nasdaq, though the company may be eligible for additional time or an appeal to a Hearings Panel.

• Company's Intent

  Biofrontera Inc. intends to actively monitor its stock price and consider available options to resolve the deficiency and regain compliance with Nasdaq Listing Rules.

auto_awesomeAnalysis

Biofrontera Inc. has received a formal notice from Nasdaq regarding its non-compliance with the minimum $1.00 bid price requirement. This is a critical event as failure to regain compliance within the 180-day period could lead to the delisting of its common stock from The Nasdaq Capital Market. Delisting typically results in reduced liquidity, decreased investor confidence, and a potential shift to over-the-counter markets, which can significantly impact shareholder value. While the company has options, including a potential reverse stock split, such actions often carry negative sentiment as they do not address underlying business fundamentals. Investors should closely monitor the company's strategy and progress in addressing this deficiency.